Vincenzo Di Lauro

5PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersPlant pathologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 06, 2026
Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Roberto Buonaiuto, Aldo Caltavituro, Rossana Di Rienzo

|Dec 11, 2025
Healthful and Unhealthful Plant-Based Diets and Their Association with Cardiometabolic Targets in Women Diagnosed with Breast Cancer: A Cross-Sectional Analysis of a Lifestyle Trial.

Sara Vitale, Elvira Palumbo, Angela D'Angelo

|Oct 29, 2025
Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors.

Anita Minopoli, Piergiacomo Di Gennaro, Giuseppe Porciello

|Sep 27, 2025
Breast Immunology Network: Toward a Multidisciplinary and Integrated Model for Breast Cancer Care in Italy.

Andrea Botticelli, Ovidio Brignoli, Francesco Caruso

|Aug 22, 2023
Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion.

Roberta Caputo, Giuseppe Buono, Vincenzo Di Lauro

Pageof 1

Frequent Collaborators

3 joint publications

Michelino De Laurentiis

2 joint publications

Giuseppe Buono

2 joint publications

Jerry Polesel

2 joint publications

Martina Pagliuca